Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes
about
Crystal Structures of Matriptase in Complex with Its Inhibitor Hepatocyte Growth Factor Activator Inhibitor-1Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptaseMatriptase zymogen supports epithelial development, homeostasis and regenerationMembrane-anchored serine proteases in vertebrate cell and developmental biologyThe protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.Transport via the transcytotic pathway makes prostasin available as a substrate for matriptaseMatriptase protects against experimental colitis and promotes intestinal barrier recoveryHepatocyte growth factor activator inhibitor-2 prevents shedding of matriptaseHepatocyte growth factor activator inhibitor-1 has a complex subcellular itineraryProstasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.A recombinant matriptase causes an increase in caspase-3 activity in a small-intestinal epithelial IEC-6 line cultured on fibronectin-coated plates.The structural requirements of matriptase in its ectodomain release in polarized epithelial cells.Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.Matriptase does not require hepatocyte growth factor activator inhibitor type-1 for activation in an epithelial cell expression model.The occurrence of matriptase C-terminal fragments on the apical and basolateral sides of Madin-Darby canine kidney epithelial cells.Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease.Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.Involvement of the cytoplasmic juxtamembrane region of matriptase in its exclusive localization to the basolateral membrane domain of Madin-Darby canine kidney epithelial cells.Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain.Enhanced truncated-t-PA (CT-b) expression in high-cell-density fed-batch cultures of Pichia pastoris through optimization of a mixed feeding strategy by response surface methodology.Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization.
P2860
Q27676642-53D05046-8CE0-4532-904A-ABDD2403D1E7Q28572367-75A7FD32-59AD-412A-895B-4933FDD8DA57Q33749952-1EA0B722-F702-43FB-B7BB-97CCACFB5271Q33948580-586F23B2-E9A1-43E0-910E-23E59DC546D6Q34070450-DCEAD2DE-5E92-4AC6-918C-1487DDEA176AQ34568634-B092CE0A-762F-4AB1-8893-C00FFD323010Q35785774-29B8F40C-0A85-4809-8821-3F8EFE31E5F3Q36735176-5CA862AD-FC84-40D5-90B3-5D1B870B44F2Q36753781-9799E82D-DCD1-4563-ABF3-1AB9D677AB32Q36760282-01986D88-BDC3-4C17-B288-384F66E5ED3EQ36923138-1C847741-D601-4438-9FFE-7701125EE6CEQ38598028-ECB53DC6-B84A-4B21-99A1-6EAAB7FA7D54Q39695753-FC0684AA-CDD6-483A-9BD0-B8CDE21C90AFQ39697447-BA33A0E1-38CE-4ACB-9F2E-E350E27DF660Q39716974-D7607F5F-BF0E-4E70-B145-60D729BFE006Q39777502-55B50E66-8573-4005-A2D6-41B73467E584Q39782275-49FDD77A-5161-415C-BF37-5DD14F3BEA15Q39816749-99A8D597-615E-42F7-A30D-BA6E29AC689BQ41838674-AEBFCF23-1E28-486B-8041-D36D7F00ED7AQ41889043-698A2BA7-E1FC-450F-85BE-6276750BE1F8Q42399102-A5F5209E-8CBF-463D-BDD2-2A7AC100CAB9Q45904382-02B460F4-A234-48F9-8619-896B1C5F854FQ50736521-67D4BFC0-3E17-45DF-93FE-76E26AF4CA79Q51221442-DFF12906-7898-4DBE-A272-ED798EE7D16A
P2860
Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes
description
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/06/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/06/01)
@nl
наукова стаття, опублікована в червні 2005
@uk
مقالة علمية (نشرت في يونيو 2005)
@ar
name
Evidence for the occurrence of ...... solateral sides of enterocytes
@ast
Evidence for the occurrence of ...... solateral sides of enterocytes
@en
Evidence for the occurrence of ...... solateral sides of enterocytes
@nl
type
label
Evidence for the occurrence of ...... solateral sides of enterocytes
@ast
Evidence for the occurrence of ...... solateral sides of enterocytes
@en
Evidence for the occurrence of ...... solateral sides of enterocytes
@nl
prefLabel
Evidence for the occurrence of ...... solateral sides of enterocytes
@ast
Evidence for the occurrence of ...... solateral sides of enterocytes
@en
Evidence for the occurrence of ...... solateral sides of enterocytes
@nl
P2093
P2860
P356
P1433
P1476
Evidence for the occurrence of ...... solateral sides of enterocytes
@en
P2093
Hirofumi Hirayasu
Kuniyo Inouye
Nobuhito Murai
Satoshi Tsuzuki
Tohru Fushiki
Toshihiko Iwanaga
Yuka Miyake
P2860
P304
P356
10.1042/BJ20041639
P407
P577
2005-06-01T00:00:00Z